Dr. Monica Beaulieu
Jun 14, 2010
New study on the use of erythropoietin stimulating agents in chronic kidney disease has made us evaluate the risk-benefit of ESA’s in CKD patients not on dialysis.
The evidence strongly suggests that there is little to no benefit gained by raising the Hb over > 100g/L (and perhaps even lower) in diabetic patients with CKD not on dialysis. read more...
Dr. Steve Wong
Apr 20, 2010
Choosing antihypertensive combos: does it matter how you do it?
I generally started with thiazide diuretics (due to cost and proven effectiveness) then added either an ACE inhibitor (ACEi) or a calcium channel blocker (CCB), consistent with the Canadian Hypertension Society Guidelines. read more...
Dr. Natasha Press
Apr 16, 2010
MRSA skin and soft tissue infections
A 32 year old woman, otherwise healthy, presented with a “spider-bite”. On exam, she had a tender abscess on her buttock. It was associated with some surrounding cellulitis but no fever or other systemic features. read more...
Dr. Breay Paty
Apr 15, 2010
What are the CV risks of TZDs: have the safety questions been answered?
Since their introduction, certain contraindications and side effects have been well known, including worsening heart failure, edema (including macular edema) and weight gain. read more...
Recent Comments